{
    "organizations": [],
    "uuid": "322a3c67f03db525d06ab0db6162bd5389aa78fb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mayne-pharmas-nda-for-suba-itracon/brief-mayne-pharmas-nda-for-suba-itraconazole-capsules-accepted-for-review-by-u-s-fda-idUSFWN1S80P1",
    "ord_in_thread": 0,
    "title": "BRIEF-Mayne Pharma's NDA For Suba-Itraconazole Capsules Accepted For Review By U.S. FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - Mayne Pharma Group Ltd:\n* NEW DRUG APPLICATION FOR SUBA-ITRACONAZOLE CAPSULES ACCEPTED FOR REVIEW BY U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-02T03:35:00.000+03:00",
    "crawled": "2018-05-02T04:08:23.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "mayne",
        "pharma",
        "group",
        "ltd",
        "new",
        "drug",
        "application",
        "capsule",
        "accepted",
        "review",
        "food",
        "drug",
        "administration",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}